Skip to content
healthcare.dev

TOFACITINIB CITRATE

NDC 85972-122, TOFACITINIB CITRATE, tablet, film coated, from Stellon Biotech Inc..

Product NDC
85972-122
Status
Listed
Labeler
Stellon Biotech Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218821
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85972-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE16.16 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
85972-122-608597201226060 TABLET, FILM COATED in 1 BOTTLE (85972-122-60)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89eb2ffc-02d9-4b46-b480-e9b10af33027

Use it

Look up 85972-122 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85972-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85972-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.